Other
Derivative, Excluded Component, Gain (Loss), Recognized in Earnings
Medtronic Derivative, Excluded Component, Gain (Loss), Recognized in Earnings increased by 5.0% to $42.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 16.0%, from $50.00M to $42.00M. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
StatementIncome Statement
SectionOther
CategoryRisk
SignalLower is better
VolatilityModerate
First reportedQ1 2023
Last reportedQ3 2026Feb 24, 2026
How to read this metric
Minimal impact is generally preferred to ensure the primary hedge relationship remains the dominant driver of results.
Detailed definition
The gain or loss recognized in earnings related to the components of a derivative instrument that were excluded from the...
Peer comparison
Standard for sophisticated treasury departments managing complex derivative portfolios.
Metric ID:
other_derivative_excluded_component_gain_loss_recognized_757d2eHistorical Data
12 periods
| Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $21.00M | $27.00M | $26.00M | $49.00M | $50.00M | $49.00M | $50.00M | $47.00M | $50.00M | $45.00M | $40.00M | $42.00M |
| QoQ Change | — | +28.6% | -3.7% | +88.5% | +2.0% | -2.0% | +2.0% | -6.0% | +6.4% | -10.0% | -11.1% | +5.0% |
| YoY Change | — | — | — | +133.3% | +85.2% | +88.5% | +2.0% | -6.0% | +2.0% | -10.0% | -14.9% | -16.0% |
Range$21.00M – $50.00M
CAGR+28.7%
Avg YoY Growth+29.4%
Median YoY Growth+2.0%
Derivative, Excluded Component, Gain (Loss), Recognized in Earnings at Other Companies
Frequently Asked Questions
- What is Medtronic's derivative, excluded component, gain (loss), recognized in earnings?
- Medtronic (MDT) reported derivative, excluded component, gain (loss), recognized in earnings of $42.00M in Q4 2025.
- How has Medtronic's derivative, excluded component, gain (loss), recognized in earnings changed year-over-year?
- Medtronic's derivative, excluded component, gain (loss), recognized in earnings decreased by 16.0% year-over-year, from $50.00M to $42.00M.
- What does derivative, excluded component, gain (loss), recognized in earnings mean?
- Earnings impact from parts of a derivative contract not included in the primary hedge effectiveness test.